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Abstract 
Parkinson’s disease (PD) is a movement disorder of the brain which is hallmarked by the 
presence of large protein-rich cytoplasmic aggregates, called Lewy bodies (LBs), in the 
neurons. The protein α-synuclein (α-syn) is abundant in these aggregates, and can itself form 
aggregates. Several mutations linked to α-syn are also linked to an increased risk of 
contracting PD. In healthy neurons, the chaperone heat shock protein 70 (Hsp70) is able to 
refold misfolded proteins such as aggregated α-syn, with the help of its co-chaperones, the 
DNAJ proteins. In addition, toxic protein aggregation is normally stopped by the unfolded 
protein response (UPR) in the endoplasmic reticulum, including the protein Ire1 which 
indirectly activates genes involved in protein folding. Here, it is shown that knocking out the 
DNAJ protein DNAJB1 in HEK293 cells overexpressing α-syn, by use of CRISPR/Cas9 
technology, leads to a significant increase of α-syn aggregates. In addition, reintroducing the 
DNAJB1 gene into these knockout cells decreases the aggregate percentage to a level 
comparable with control cells. Furthermore, introducing a H32Q mutant version of DNAJB1, 
which cannot interact with HSP70, into the knockout cells, does not decrease the level of α-
syn aggregation. This suggests that the DNAJB1 protein may have an important function in 
suppressing the formation of the toxic α-syn aggregates in cells and could be involved in a 
potential new PD therapeutic. Furthermore, the effect of conditionally knocking out the UPR 
protein Ire1 in the dopaminergic neurons of a Parkinsonian mouse model expressing human 
α-syn-GFP has been investigated. After 6 months, the lack of the protein does not seem to 
result in a behavioral difference in the mice compared to control, and thereby does not share 
the therapeutic potential of DNAJB1.  
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Introduction 
Neurodegenerative diseases are defined as chronic disorders caused by progressive loss of 
neurons in the central nervous system 1. Depending on the disease, this can have several 
different detrimental effects for the patient. One of the most common neurodegenerative 
diseases is Parkinson’s disease (PD), whose cardinal symptoms are tremors, rigidity, and 
postural imbalance, and is characterized by the degeneration of dopaminergic neurons in the 
substantia nigra pars compacta of the brain 2.  
A hallmark of PD is the formation of large protein-rich cytoplasmic aggregates called Lewy 
bodies (LBs). The most abundant protein in these aggregates is a small 140-amino acid 
protein named α-synuclein (α-syn), which is mainly found in the central nervous system and 
is widely expressed in the neurons of the brain. The role of α-syn in the cell has not been 
completely deciphered, but studies have suggested that it has an important role in the 
presynaptic terminal, where it is believed to associate with SNARE proteins and thereby aid 
in the vesicle release during synapse transmission. Furthermore, missense mutations and 
multiplications of the SNCA gene, which encodes for α-syn, have been linked to PD 3. 
The aggregation of α-syn to form fibrils, which partake in LB formation, is not exclusive only 
to PD. Indeed, the several diseases that involve similar α-syn inclusions are categorized under 
the umbrella term synucleinopathies 3. In fact, accumulation of misfolded proteins is a 
common denominator of not only synucleinopathies, but of several neurodegenerative 
diseases, explaining why the cell has numerous mechanisms with the purpose of maintaining 
correct protein folding and preventing toxic aggregation. One of these mechanisms involves 
the molecular chaperone family of 70-kDa heat shock proteins (Hsp70s), which are involved 
in several folding processes including folding of newly synthesized proteins as well as 
refolding of misfolded and aggregated proteins. Indeed, Hsp70 has been shown to prevent the 
dopaminergic neuronal loss associated with PD 4. Hsp70 binds to hydrophobic protein regions 
and utilizes ATP hydrolysis to energize the refolding of misfolded proteins 5, but cannot 
accomplish this without a family of co-chaperones, the DNAJ proteins, which supply the 
misfolded protein substrate and stimulate ATP hydrolysis. 
The human genome encodes over 40 different DNAJ proteins, all of which contain the J 
domain that is used to bind Hsp70 6. Among these is the cytosolic protein DNAJB1, which is 
constitutively expressed in neuronal tissue 7 and is upregulated during heat shock stress. 
Overexpression of DNAJB1 in polyglutamine disease mouse models using viral vectors has 
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been shown to suppress polyglutamine inclusion formation. In addition, stress-responding 
DNAJB1 has been suggested to be released into the extracellular space through an exosomal 
pathway, and subsequently to be internalized into neighboring cells to promote their 
proteostasis 8. Furthermore, in vitro studies combining the Hsp70 family member Hsc70 with 
an Hsp110 family nucleotide exchange factor and DNAJB1 have shown the ability to 
disaggregate α-syn fibrils 9.   
In addition to DNAJB1, another DNAJ protein that has been studied in the context of 
aggregated proteins is DNAJB6. DNAJB6 is present in neurons and has two isoforms; the 
longer DNAJB6a which is predominantly localized in the nucleus, and the shorter DNAJB6b 
which is more common cytoplasmically10. DNAJB6 has indeed been shown to be present in 
LBs in PD patients11. Furthermore, the protein has been shown to reduce the aggregation of 
polyglutamine in vivo12. Moreover, Hansen et al. (unpublished data, 2017) have shown that 
knocking out the DNAJB6 gene in α-syn-dsRed-overexpressing cells leads to a significant 
increase in α-syn aggregates, an effect that is reversed by the reintroduction of DNAJB6.  
The work of chaperones such as Hsp70 and co-chaperones like DNAJB1 and DNAJB6 play 
an important role against upheaval of the cell’s protein homeostasis. However, should this 
defense fail, there are numerous further protective mechanisms to ensure proteostasis. Firstly, 
misfolded proteins that are unable to be refolded become targeted for endoplasmic reticulum-
associated degradation (ERAD). If this contribution still does not restore the protein balance 
of the cell, the ER will induce the unfolded protein response (UPR) 13.  
There are three main pathways that are activated in the UPR: the Activating Transcription 
Factor 6 (ATF6) pathway, the PKR-like endoplasmic reticulum kinase (PERK) pathway, and 
the Inositol Requiring Enzyme 1 (Ire1) pathway. Normally, all these pathways are inhibited 
by binding to the endoplasmic reticulum (ER) chaperone protein BiP. When misfolded 
proteins accumulate, however, BiP dissociates from the receptors to bind to the exposed 
hydrophobic regions of misfolded proteins. This dissociation enables each pathway to become 
activated and induce downstream effects. Under these conditions, ATF6 gets exported from 
the ER and activated in the Golgi apparatus, leading to its transport to the nucleus, where it 
activates transcription of genes involved in protein folding and ERAD. PERK, in turn, gets 
trans-autophosphorylated and can thereby phosphorylate the translation initiation factor 
eIF2α, resulting in decrease of global protein synthesis and thereby a reduction of ER protein 
load. Finally, as BiP dissociates from the N terminus of the Ire1 protein, Ire1 oligomerizes 
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and autophosphorylates. This activates the ER lumen-exposed endoribonuclease domain of 
the protein, which subsequently cleaves an intron from the mRNA of the transcription factor 
XBP1, resulting in a more potent frameshift variant. XBP1, in turn, enables activation of 
genes involved in ERAD, protein folding, lipid synthesis, and RNA degradation. In addition 
to the action of this ER lumen-exposed domain of Ire1, the cytosolic kinase domain of the 
protein can promote a pro-apoptotic signal should the load of misfolded proteins increase to 
unsustainable levels. There are two different homologs of Ire1 in the body, Ire1α and Ire1β. 
Ire1β is only found in the intestine while the homolog that will be discussed in this report, 
Ire1α, is expressed throughout the body including the brain. Altogether, these pathways guide 
a protective response that includes both decrease of protein translation and upregulation of a 
specific subset of chaperones to increase the folding capacity of the cell. 14. The UPR has 
been suspected to play a part in neurodegenerative diseases involving aggregated proteins. 
Indeed, upregulation of XBP1 in a Parkinsonian mouse model has been shown to suppress the 
degeneration of dopaminergic neurons 15. In addition, overexpression of BiP reduced α-syn 
toxicity in human α-syn-expressing rats 16. 
While there are numerous additional mechanisms in the cell that assist in the clearance of 
misfolded proteins, the two that will mainly be investigated in this study are the Ire1 pathway 
and the DNAJB1/Hsp70 pathway. In this master thesis I demonstrate that knocking out 
DNAJB1 in HEK293 cells causes increased α-syn aggregation, which is dependent on the J-
domain catalytic activity of the protein. In addition, I present data from mouse models studies 
addressing whether Ire1α could play a role in PD progression.   
Materials and Methods  
DNAJB1  
Establishing DNAJB1 knockouts 
HEK293 cells overexpressing α-syn attached to a red fluorescent protein (dsRed) were used to 
induce and visualize α-syn aggregation. While HEK293 cells originate from human 
embryonic kidney, the cells show several neuronal phenotype characteristics and are therefore 
widely used in neuroscience research 17. The DNAJB1 gene was knocked out in these cells by 
CRISPR/Cas9 plasmid transfection. The CRISPR/Cas9 system originates from the adaptive 
immune response of bacteria and archaea, and utilizes a pre-designed guide RNA sequence 
that leads the protein Cas9 to the gene of interest. Cas9 then creates a double-stranded DNA 
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break at the specified location, which the cell then tries to repair, resulting in a mutation that 
in this case created a knockout of the DNAJB1 gene 18. For this system, DNAJB1-specific 
guide sequences were created and cloned into a Cas9-Green fluorescent protein (GFP) 
construct (Addgene cat# 48138).  
The insert of the guides into the plasmid was accomplished by mixing the guide RNAs with 
T4 polynucleotide kinase and T4 ligation buffer in order to promote phosphorylation and 
annealing of the oligonucleotides. A thermocycler was used with the following temperature 
differences: 37°C x 30 min, 95°C x 5 min, ramp down to 25°C at 5°C per min. The 
phosphorylated and annealed oligonucleotides were set up in a combined digestion and 
ligation reaction with the Cas9-Green fluorescent protein construct and incubated in a 
thermocycler (6 cycles of 37°C x 5 min and 21°C x 5 min). The resulting ampicillin-resistant 
plasmids with incorporated guides were transformed into competent bacteria by heat shock 
and were plated onto ampicillin-containing dishes. After overnight incubation, colonies were 
selected for Miniprep plasmid isolation (Zyppy Plasmid Miniprep Kit). The plasmids were 
sequenced to ensure correct oligo incorporation. The guide sequences used were 
5’CACCGTCTCCTCGTCCGACGCGCCG3’, 5’AAACCGGCGCGTCGGACGAGGA 
GA3’, 5’CACCGCGGGTCGCTGAGCACGTCGT3’, 5’AAACACGACGTGCTCAGC 
GACCCGC3’.  
In order to transfect the construct into the cells, plasmids and Lipofectamine LTX (Thermo 
Fisher Scientific) were separately incubated with Opti-MEM medium (Thermo Fisher 
Scientific) for 5 minutes, after which they were combined and incubated for an additional 20 
minutes. Subsequently, the solution was added to the cells dropwise. After overnight 
incubation, medium was changed, and 36 hours after transfection, GFP-positive cells were 
single sorted using Fluorescence Activated Cell Sorting (FACS). In this method, single cells 
are passed in front of a laser, which detects the fluorescence of the cell, and which 
subsequently sorts the cells emitting the fluorescence of interest into individual 96 wells 19. 
Following this, the cells were grown in DMEM (Sigma-Aldrich) plus 10% FBS (Sigma-
Aldrich) and penicillin/streptomycin (Gibco Life Technologies), and surviving colonies were 
grown in 96 well plates until they were subconfluent, and then transferred to 12 well plates.  
Identifying DNAJB1 knockouts 
Subconfluent cells from 12 well plates were detached by trypsinization and split into two 
fractions: half of them were frozen using freezing media (60% FBS, 30% medium, 10% 
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DMSO) for further investigating, and the other half was transferred into an Eppendorf tube 
after which the cells were lysed using lysis buffer (0.5% Triton X-100, 50 mM Tris/HCl pH 
7.4, 175 mM NaCl, 5 mM EDTA pH 8.0, 1% protease inhibitor mixture). The protein 
concentration was determined using the Bradford assay, in which the dye Coomassie Brilliant 
Blue G-250 is converted from its red to its blue form when bound to protein 20. Samples were 
compared to a standard with BSA concentrations ranging from 0 to 2000 µg/ml using cuvette 
spectrophotometry. Protein concentrations were used to calculate appropriate volumes of 
lysates for the western blot which was then performed. The proteins were separated in 8 % 
polyacrylamide gels (resolving gel: 2% Glycerol, 0.5M Tris pH 8.8, 0.1% SDS, Acrylamide 
8%/Bis 0.9%, 1% TEMED, 0.06% APS, stacking gel: 0.06 M Tris pH 6.8, 0.05% SDS, 
Acrylamide 2%/Bis 0.2%, 0.05% TEMED, 0.03% APS)  and were then transferred onto a 
PVDF membrane, blocked with 5% (w/v) dried skimmed milk in PBS-T (8% NaCl, 0.2% 
KCl, 1.44% Na2HPO4, KH2PO4, 0.05% Tween) and stained with a primary anti-DNAJB1 
antibody (Enzo Life Sciences, Cat# ADI-SPA-400-D) in 2% (w/v) dried skimmed milk in 
PBS-T, and a secondary HRP-conjugated goat anti-rabbit antibody (Dako) in 2% (w/v) dried 
skimmed milk in PBS-T, in order to identify knockouts. Three knockouts of DNAJB1 were 
investigated. Further lysates were made and western blot was performed a second time to 
assure that the knockouts were identified correctly. The blots were also stained with a primary 
anti-α-syn (BD, Cat# 610787) antibody to visualize the total amount of α-syn in the lysates, as 
well as with anti-phospho-α-syn (Abcam, Cat# ab59264) antibody, corresponding to the 
phosphorylated Ser129 amino acid in aggregated α-syn. Secondary antibodies used were 
HRP-conjugated goat anti-rabbit and goat anti-mouse from Dako.  
Quantifying α-syn aggregates 
50 000 cells, counted using a hemocytometer, were transferred to a 24 well plate with 
coverslips and left overnight to grow. The cells were washed with PBS (Thermo Fisher 
Scientific), fixed with 4% PFA for 20 minutes, re-washed with PBS and then mounted on a 
microscope slide using Vectashield mounting medium (H-1200, Vector) containing the DNA-
specific stain DAPI 21. Using a fluorescent microscope, at least 200 cells were photographed 
and their α-syn aggregates were counted. This was repeated three times for each sample. For 
all experiments, the knockouts were compared to a wildtype control. 
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Creating DNAJB1 and DNAJB1 H32Q plasmids 
In order to reintroduce the DNAJB1 gene into the knockouts, human DNAJB1 cDNA and 
H32Q mutant human DNAJB1 cDNA were amplified using primers containing XhoI 
(5’TCGACTCGAGCTATGGGTAAAGACTACTACCAGACGTTGGG3’) and BamHI 
(5’TCGAGGATCCCTATATTGGAAGAACCTGCTCAAGTACGGTTC3’) restriction site 
overhangs. cDNA was isolated by size through gel electrophoresis, as was Kanamycin-
resistant plasmid vector pAcGFP-1-C1 (Clontech). Subsequently, the isolated DNA was 
purified from the gel using Zymoclean Gel DNA Recovery Kit. All DNA was then digested 
by restriction nucleases BamHI and XhoI, and the plasmid vector was ligated to both variants 
separately. Afterwards, the solutions were added to competent bacteria (XL1-Blue), which 
were heat shocked to enable transformation and incubated with SOC medium (Thermo Fisher 
Scientific) for 2 hours on a shaker at 37°C. Next, the bacteria were plated onto agar plates 
containing Kanamycin and were incubated overnight. Four colonies of each sample were then 
isolated and incubated overnight in a shaker in 5 ml LB medium containing Kanamycin. The 
following day, a MiniPrep (Zyppy Plasmid Miniprep Kit) was performed to isolate the 
plasmids. To make sure that the DNAJB1 gene had successfully integrated in the plasmid, 1 
µg of the purified plasmid DNA was digested using restriction nucleases BamHI and XhoI. 
The resulting DNA was separated by size to enable identification of the DNAJB1 gene. The 
plasmid was sequenced to ensure correct integration.  
Transfection of plasmids and quantification of α-syn aggregates 
To introduce the gene into the knockout cells, the plasmids and Lipofectamine LTX (Thermo 
Fisher Scientific) were independently incubated with Opti-MEM (Thermo Fisher Scientific) 
for 5 minutes at room temperature, and subsequently combined for an additional 20 minute 
incubation. After adding the solution dropwise to 30 000 cells grown in a 24 well plate with 
coverslips overnight, the cells were incubated 24 hours. Medium was changed, and the 
following day the cells were washed with PBS, fixed with 4% PFA for 20 minutes and then 
mounted onto microscope slides using Vectashield mounting medium containing DAPI after 
an additional PBS washing. At least 200 GFP and dsRed positive cells were counted and their 
aggregates quantified. The experiment was repeated 3 times for each sample. 
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DNAJB6a knockout 
As earlier results by Hansen et al., (unpublished data, 2017) have shown that DNAJB6 is able 
to significantly suppress α-syn aggregation in HEK293 cells overexpressing α-syn-dsRed, the 
effect of knocking out DNAJB6a was investigated. The knockout of DNAJB6a was created 
using the same CRISPR/Cas9 method as the DNAJB1 knockouts, described above. The 
sequences for the guides used were 5’CACCGTCCTACAGAATTGTCGAGAA3’ and 
5’AAACTTCTCGACAATTCTGTAGGAC3’. The primary antibodies used to identify the 
knockout by western blot were anti-α-syn (BD, Cat# 610787), anti-phospho-α-syn (Abcam, 
Cat# ab59264), and anti-DNAJB6 (Abcam, Cat# ab198995). Secondary antibodies used were 
HRP-conjugated goat anti-rabbit and goat anti-mouse from Dako. The knockout cells were 
grown on coverslips, mounted onto microscope slides, and quantified in the same manner as 
the DNAJB1 knockouts described above. 
DNAJB6 and DNAJB1 double knockout 
Since both DNAJB6 and DNAJB1 show a significant increase in α-syn aggregation when 
knocked out, a double knockout of both proteins was created in α-syn-dsRed-expressing 
HEK293 cells. The knockout was created using the same method as for DNAJB1 described 
above. The sequences used for the DNAJB1 knockout were 5’CACCGTCTCCTCGTCCG 
ACGCGCCG3’, 5’AAACCGGCGCGTCGGACGAGGAGA3’, 5’CACCGCGGGTCGCT 
GAGCACGTCGT3’, and 5’AAACACGACGTGCTCAGCGACCCGC3’. The sequences 
used for DNAJB6 knockout were 5’CACCGGGAGGCATATGAAGTGCTGT3’ and 
5’AAACAGATATCGGAAACTGGCACTC3’. The antibodies used for western blot were 
anti-DNAJB1 antibody (Enzo Life Sciences, Cat# ADI-SPA-400-D) and anti-DNAJB6 
(Abcam, Cat# ab198995). The secondary antibody used was HRP-conjugated goat anti-rabbit 
from Dako. 
Ire1 knockout mice 
Generation of transgenic mice 
Hansen et al., 2013 have previously established a mouse model of Parkinson’s disease, where 
human α-syn attached to GFP is expressed under control of the endogenous mouse α-syn 
promoter through pronuclear injection of a bacterial artificial chromosome 22. This model 
mouse was used in the following experiments to investigate the effect of knocking out the 
Ire1α gene in wildtype and Parkinson-model mice. All mice used were female; as Hansen et 
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al., 2013, showed that the Parkinsonian symptoms were more abundant in female α-syn-GFP 
expressing mice than in males. 
In order to create mice with a conditional dopaminergic knockout of Ire1, the Cre-Lox method 
was used. Mice with Cre recombinase expressed on their dopaminergic neurons (The Jackson 
Laboratory), courtesy of the endogenous dopamine transporter promoter, were bred with mice 
that have loxP flanking their Ire1α gene. By loxP-specific recombination, Cre recombinase 
deleted the Ire1α gene 23. Breeding the α-syn-GFP-expressing mice with the conditional 
dopaminergic Ire1 knockout mice resulted in the main mouse model investigated in the study: 
a Parkinson model mouse with a conditional knockout of the Ire1α gene. In addition to this 
model, three control groups were tested, resulting in the following four groups being studied; 
1. Wildtype Ire1α and no expression of human α-syn-GFP 
2. Conditional Ire1α knockout and no expression of human α-syn-GFP 
3. Wildtype Ire1α and expression of human α-syn-GFP 
4. Conditional Ire1α knockout and expression of human α-syn-GFP 
Genotyping 
Mouse ear biopsies were analyzed using genotyping lysis buffer (50 mM Tris pH 8.0, 5 mM 
EDTA, 100 mM NaCl, 0.5% SDS) in combination with Proteinase K  at 56ºC overnight. 
Subsequently, DNA was precipitated by addition, incubation, centrifugation and removal of 
saturated NaCl followed by addition, centrifugation and removal of 99% ethanol. 70% ethanol 
was used to wash the DNA pellet before resuspension in 10 mM Tris pH 7.4, 0.1 mM EDTA. 
Using α-syn-GFP and dat-cre primers, specific for the α-syn-GFP gene and the Cre 
recombinase gene, respectively, PCR was performed. The presence of the amplified genes 
was analyzed by size through agarose gel electrophoresis. 
Behavioral tests 
Behavioral test were performed on all animals at around 3 and 6 months of age. The two tests 
that were used are the rotarod assay and the open field assay. Before all experiments the mice 
were allowed to familiarize themselves with the test room for one hour. The number of mice 
used for the tests were as follows (Ire1α-/αsyn-, Ire1α+/αsyn-, Ire1α-/αsyn+, Ire1α+/αsyn+ 
respectively): 3 months of age (10, 7, 8, 11), 6 months of age: (4, 7, 1, 9). 
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Rotarod 
The rotarod assay allows the animals to walk on an accelerating rod in order to assess the 
motor abilities and balance of the animals (Rotamax 4/8, Columbus Instruments, USA, 3.8 cm 
rod diameter, 4.5 cm wide) 24. Prior to testing, the mice were pre-trained by walking for 20 
seconds at a rod rotating at a speed of 5 rounds per minute (rpm). Subsequently, the mice 
were placed on the rod once more as the speed increased gradually from 5 to 40 rpm over 5 
minutes. When a mouse fell down from the rod the time was stopped and noted. 4 trials (two 
each day, with at least an hour between each trial) were averaged. If the mouse held on to the 
rod or by other means stayed on the rod without running or walking, the trial ended there, for 
the purpose of measuring the same kind of motor abilities in all mice. The rotarod machine 
was cleaned with 30 % ethanol between each animal.  
Open field assay 
The open field assay placed the animals in 40.6×40.6×38.1 cm (d×w×h) plexiglass chambers 
cleaned with water and 30 % ethanol. The mice were allowed to explore the cage freely for 
one hour while their movements were recorded using an infrared photobeam system, where 
beam-breaks were recorded 25. The purpose of this test was to record the total distance the 
animals moved during the hour, to assess locomotor activity. After resting for at least an hour, 
animals were intraperitoneally injected with 5 mg/kg amphetamine in saline solution and the 
test was immediately repeated. Amphetamine causes an inhibition of the dopamine transporter 
(DAT) leading to increase of dopamine in the synaptic cleft of dopaminergic neurons, causing 
an activation of these synapses 26. Hence, the injection of amphetamine activates the neurons 
of the substantia nigra pars compacta that should be relevant in Parkinson’s disease. Between 
all tests the cages were cleaned. Results were analyzed using the ANY-maze software.  
Statistics 
The significance of the results was analyzed using student’s t test, and variance was 
investigated by standard deviation, for all experiments.  
Results 
DNAJB1  
To investigate whether DNAJB1 may play a role in α-syn aggregation, we decided to knock 
out DNAJB1 with the help of specific DNAJB1 gene targeting RNA guides by the use of the 
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CRISPR/Cas9 system. The cell line of choice for the study was HEK293 cells overexpressing 
a transgene of dsRed fused to the C-terminus of α-syn. Cells transiently transfected with guide 
RNA and GFP-Cas9 were sorted by FACS 36 hours after the transfection and surviving 
potential knockout colonies were grown in 96 well plates. Subsequently, cell lysates were 
analyzed by western blot, leading to the discovery of three independent complete DNAJB1 
knockout cell lines (Figure 1 A). Furthermore, these cell lines were analyzed using antibodies 
reflecting total α-syn level, phospho-Ser129-α-syn level, as well as actin loading control. The 
clones were shown to have a similar total α-syn level, while the phospho-Ser129-α-syn level, 
which is a known marker of α-syn aggregation 27, was higher in knockout 3 than in wildtype 
and both the other knockouts (Figure 1 A).  
When visualizing the knockout and wildtype cells using fluorescence microscopy, 
significantly more red puncta (interpreted as α-syn aggregates) were seen in the knockouts 
than in the control (Figure 1 C). Around 8.4% of the knockout cells had red puncta compared 
to 3.4% cells of the wildtype (Figure 1 B). To confirm that the increase in red puncta in the 
knockouts was indeed due to lack of DNAJB1, a GFP-tagged version of DNAJB1 was 
reintroduced into the cells by transfection (Figure 2 B). The reintroduction of DNAJB1 
resulted in a significant decrease of α-syn aggregates to around 4.4% in knockout 1 (Figure 2 
A). Similar significances were seen in all three knockouts. 
In order to verify that the decrease of aggregates after DNAJB1 reintroduction was due to 
DNAJB1 interacting with Hsp70 through its J domain, a control experiment was set up. By 
using a mutated version of DNAJB1 H32Q, which cannot interact with Hsp70, it was possible 
to confirm the importance of the J domain for the interaction between chaperone and co-
chaperone 28. Indeed, transfection of H32Q DNAJB1 into DNAJB1 knockout cells did not 
decrease the amount of red puncta in the cells significantly, and the aggregate percentage was 
quantified to 8.3% in knockout 1 (Figure 2 A, Figure 2 C), with similar results in the other 
knockouts. This suggests that the J domain, and thereby the interaction with Hsp70, is vital to 
the α-syn-disaggregating properties of DNAJB1. 
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Earlier work by Hansen et al., (unpublished data, 2017) has shown that knocking out the 
DNAJ protein DNAJB6 in α-syn-dsRed-expressing HEK293 cells leads to a significant 
increase in α-syn aggregates. In aforementioned study, both isoforms of DNAJB6, DNAJB6a 
and DNAJB6b, were knocked out. In continuation with this work, a knockout of only the 
DNAJB6a isoform was investigated, in order to examine the individual abilities of the 
isoform. A knockout was accomplished and confirmed by western blot, after which levels of 
total α-syn as well as phospho-α-syn were investigated (Figure 3A). The levels of both the 
aggregation-dependent phospho-α-syn as well as the total α-syn levels were similar in both 
knockout and wildtype. Subsequently, the percentage of red puncta was quantified as 
described earlier, and there was shown not to be any significant difference between knockout 
and wildtype (Figure 3B). While the DNAJB6a isoform alone does not seem to have an effect 
on the aggregation of α-syn, the complete knockout of DNAJB6 still gives a pronounced 
effect, similar to the clear effect of a DNAJB1 knockout. Therefore, a double knockout of the 
two proteins was made (Figure 3C), to enable further investigation of their effect on α-syn 
aggregation. 
Altogether, these results suggest that DNAJB1 has a disaggregating effect on α-syn that leads 
to an increase in aggregates when the protein is knocked out. The α-syn aggregate 
suppressing characteristics of DNAJB1 are dependent on its interaction with Hsp70 through 
the J domain. On the other hand, the α-syn aggregate suppressing features of the DNAJB6 
protein do not seem to be due to the DNAJB6a isoform, but more likely because of the 
DNAJB6b isoform. By producing a combined knockout of both DNAJB1 and DNAJB6, 
further studies can be made on the effects of these proteins on α-syn aggregation.  
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The open field assay measures the locomotor activity of the mice during a one hour long 
exploration of a plexiglass chamber. The mice were first tested without any treatment, and 
then tested again after an amphetamine injection (5 mg/kg), to cause increase of extracellular 
dopamine and activation of dopaminergic synapses. At 3 months, no treatment, there is no 
significant difference in locomotor activity between the four groups (Figure 5 A). When the 
mice are injected with amphetamine, however, a significant difference emerges between (tg 
Ire/wt α-syn-GFP) and (wt Ire/tg α-syn-GFP) groups, where the (tg Ire/wt α-syn-GFP) has a 
lower distance travelled than the (wt Ire/tg α-syn-GFP) (Figure 5 B). After 6 months, no 
treatment, there still is no significant difference between any of the groups (Figure 5 C). 
However, there is only one value measured from the (wt Ire/tg α-syn-GFP) group and 
therefore significance calculations involving this group cannot be performed. In addition, it is 
discouraged to draw conclusions from this value in the amphetamine treatment (Figure 5 D), 
as it may look much lower than the rest but is still the result of only one mouse which may or 
may not be an outlier. The other groups do not show any significant differences under 
amphetamine treatment.   
Altogether, the gross motor skill measured by the rotarod test appears unaffected by the 
genetic alterations after 3 and 6 months. Similarly, the locomotor activity of the mice without 
treatment is seemingly comparable between groups. While the amphetamine-treated 3 month 
old mice seem to exhibit a significance between two groups, the change cannot be tracked at 6 
months due to lack of mice. 
Discussion 
DNAJB1 
Using DNAJB1 knockout HEK293 cells overexpressing α-syn-dsRed have shown the ability 
of DNAJB1 to suppress α-syn aggregate formation by exposing a significant increase of α-
syn aggregates when the gene is knocked out (Figure 1 C). In addition, this upsurge is 
diminished when DNAJB1 is reintroduced into the cell by transfection (Figure 2 A). 
However, the introduction of a DNAJB1 H32Q mutant, which cannot interact with Hsp70 due 
to a substitution in its J domain, cannot decrease the amount of α-syn aggregates in the cells 
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(Figure 2 A). This suggests that it is, in fact, the interaction with Hsp70 through the J domain 
that is the main pathway of α-syn disaggregation for DNAJB1.  Similarly, previous studies 
have shown that poly-Q inclusion formation is decreased by the presence of DNAJB1, but 
only when its J domain is non-mutated 28.  
In addition, western blot staining (Figure 1 A) showed that while the total α-syn aggregation 
levels remain similar between knockout and wildtype, the amount of phosphorylated α-syn 
seems to be increased in one knockout clone only. Since only three clones are investigated, it 
is difficult to state whether the effect is individual to this clone only or if the phosphorylated 
α-syn level is heightened in a larger percentage of the DNAJB1 knockouts. Since 
phosphorylation of α-syn is a post-translational modification that is enhanced in Lewy Bodies 
and correlated to increased aggregation of the protein, these results would suggest that the 
third knockout has a higher level of aggregation than control and both of the two other 
knockouts 22. The fact that the total α-syn level remains steady between clones suggests that 
the third clone does not have increased α-syn. In addition, when the fluorescence microscopy 
quantification is compared between clones, the third knockout does not have a significantly 
larger percentage of aggregates than the other knockout clones (Figure 2 A). Therefore, the 
reason for this difference is not easily explainable, but could be attained to an increased 
amount of post-translational phosphorylation, or to the aggregates themselves having more 
phosphorylated α-synuclein exposed to the reach of antibodies.  
While the disaggregation results are promising, there are several interesting experiments that 
could be done in this area in the future. Firstly, it would be interesting to further investigate 
the interaction between Hsp70 and DNAJB1 by for example an Hsp70 inhibitor. By inhibiting 
Hsp70, one could investigate if DNAJB1 has further beneficial effects in the cell 
independently of Hsp70 when its J domain is not mutated. In addition, the results could be 
cemented by further experiments measuring the difference of α-syn aggregate levels between 
knockout and control. LBs and other large pathological α-syn aggregates in PD have been 
shown to be insoluble, a fact that could be used to separate from the soluble fraction and 
quantify them29. If, however, the red puncta viewed in the fluorescence microscope are not in 
fact insoluble, native gels could be used to visualize the aggregates, since native gels allow 
complexes of protein to remain folded as they were in the cell30. 
Furthermore, there is a third partner in the disaggregating activity that could be investigated: 
the nucleotide exchange factors (NEFs). Their role in the activity of DNAJ and Hsp70 is to 
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escalate replacement of ADP with ATP, and thereby to increase the rate of disaggregation 31. 
There is a lot of diversity in the family of NEFs in human cells, and it has been found that 
different NEFs can have very different levels of disaggregation enhancement. Apg2 and 
Hsp105α of the Hsp110 NEF family, for example, have been shown to increase 
disaggregation efficiency in combination with Hsp70 and DNAJB1, while NEF Bag-1 does 
not 9. Indeed, the ineffectiveness of Bag-1 together with DNAJB1 and Hsp70 has been shown 
in Poly-Q inclusions, as well 28. Therefore, in the future it might be interesting to further 
investigate the particular NEFs that work best together with DNAJB1.  
PD is known to cause degeneration of dopaminergic cells, and therefore an additional relevant 
experiment would be to investigate the effect knocking out DNAJB1 has on cell death. In 
addition, the cells we use in this study are originally human embryonic kidney cells. While 
HEK293 cells have been shown to possess several neuronal phenotype characteristics17, it is 
important to continue these studies in an actual neuronal cell line, such as the neuroblastoma 
cell line Neuro-2A32. Indeed, as the project progresses, it would be interesting to move the 
search into a primary neuronal cell line, where there is potential to dissect out dopaminergic 
neurons exclusively. Furthermore, it would give the possibility to study typically neuronal 
characteristics, such as axonal function, more closely. In fact, α-syn has been shown to 
accumulate in axons in primary neurons that have been seeded with preformed α-syn fibrils29.  
Subsequently, there are several possible in vivo models that could be relevant. Firstly, a 
knockout model of DNAJB1 is yet to be produced, but by using the Cre-LoxP method 
similarly to the way the Ire1 knockout mice were created in this report, a line of knockout 
mice could be made. This line could then be mated with PD model mice, producing a 
DNAJB1 knockout PD mouse that could be used for both behavioral test and brain studies. 
Secondly, it has been shown that the use of recombinant adeno-associated viral vectors 
(rAAV) that express human α-syn leads to progressive loss of dopaminergic neurons in 
substantia nigra pars compacta. Therefore, rAAVs expressing α-syn can readily be used as 
PD models33. In addition, these viruses can be used to overexpress promising therapeutic 
proteins such as DNAJB1 in the brain, to analyze the effects on behavior. Furthermore, rAAV 
could be used to combine overexpression of DNAJB1 with overexpression of a NEF deemed 
appropriate through cell studies, to increase efficiency of the chaperone system. Another 
alternative is to induce PD-like symptoms in DNAJB1 knockout animals using the rAAV 
virus.  
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While there are indeed multiple possible experiments concerning DNAJB1, there is also the 
possibility to further explore the double knockout of DNAJB1 and DNAJB6. Since these 
proteins both have similar effects on the aggregation of α-syn, reintroduction tests may shed a 
light on whether the mechanisms of these proteins in relation to Hsp70 differ completely or 
are functionally redundant.  
In order to further understand the future results of analyzing the double knockouts, it is 
important to analyze the results of the DNAJB6a knockout. Since the percentages of red 
puncta in wildtype control and DNAJB6a are not significantly different (Figure 3B),  the main 
disaggregating effect of DNAJB6 on α-syn aggregates must stem from the DNAJB6b isoform 
or the combination of both DNAJB6a and DNAJB6b. α-syn has been shown to be expressed 
in both nucleus and cytoplasm, while DNAJB6b is mostly cytosolic and DNAJB6a is mostly 
nucleic10. A possible explanation for the indifferent results of the DNAJB6a knockout and 
control could be that the majority of the aggregates of the α-syn-dsRed model used in these 
experiments are localized to the cytoplasm, even though α-syn is expressed in both nucleus 
and cytoplasm. That would result in a decreased effect of DNAJB6a, as it is located to the 
nucleus. Therefore, it may be beneficial to further analyze the model used, and where the 
majority of the α-syn-dsRed aggregates reside. To sufficiently rule out any potential benefits 
of DNAJb6a, it could also be useful to overexpress it in a DNAJB6 knockout cell line, to see 
if it could rescue the induced aggregation alone.  
Ire1 
The role of one of the main three UPR pathways, the Ire1 pathway, was investigated in this 
study by knocking out the Ire1α gene in mice with overexpression of α-syn-GFP. Since the 
UPR has an important role in maintaining cellular protein homeostasis, this genetic change 
was hypothesized to result in an increase of aggregated α-syn in neurons, leading to death of 
dopaminergic neurons and thereby a decrease in the motor control of the mice. This was 
tested through behavioral tests. However, at 3 months old, there was no significant difference 
between groups in either of the tests. The reason for this could be that the mice are young, and 
that the aggregation of α-syn has yet to give an observable effect in behavior, which would be 
consistent with the fact that age is a risk factor for PD. Indeed, the α-syn-GFP-expressing 
mouse model used to represent PD did not show any significant behavioral differences at 
three months of age, which could explain the results. However, the mouse model did show a 
significant decrease in locomotor activity in the open field assay when administered with 
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amphetamine at 7 months 22, a difference that was not seen in this study at 6 months. The only 
significance seen at 6 months was that between (tg Ire/wt α-syn-GFP) and (wt Ire/tg α-syn-
GFP). However, since these two groups show no significant difference to any of the two other 
controls, and since they share no variable, it is difficult to draw any sustainable conclusion 
from this result.  
While the results seem to be similar between all groups at 6 months, it is still interesting to 
continue the study up to 9 and 12 months, since PD is an age-related disease. In addition, the 
mouse model used showed no significant differences between groups in the rotarod assay 
until 12 months of age was reached. Therefore, the effect of Ire1 might be present but strongly 
age-related. Furthermore, it could be worth-while to sacrifice some 12 month old mice, to 
investigate the effect of the knockout on the neuronal tissue. This might clear up if the α-syn 
aggregation has increased in the knockout mice, compared to control, and if it has had an 
effect on the amount of dopaminergic neurons.  
Conclusion 
In conclusion, knocking out DNAJB1 in α-syn-dsRed overexpressing HEK293 cells leads to 
an increase in red puncta, which we interpret as α-syn aggregates. Reintroducing DNAJB1 to 
the cells through plasmid transfection leads to an upsurge in disaggregation, resulting in an α-
syn aggregate level comparable to control, an effect which seems dependent on the function 
of the J domain. Knocking out Ire1 in α-syn-GFP-expressing mice, on the other hand, does 
not seem to have an effect on the motor behavior of the mice. However, considering that age 
is a common risk factor for PD, the effect of the knockout may become more visible as the 
mice grow older. 
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